HEADER HYDROLASE/HYDROLASE INHIBITOR 25-MAY-22 8CZX TITLE STRUCTURE OF SARS-COV-2 3CL PROTEASE IN COMPLEX WITH THE CYCLOPROPANE TITLE 2 BASED INHIBITOR 17D COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3CL-PRO, 3CLP, MAIN PROTEASE, MPRO, NON-STRUCTURAL PROTEIN COMPND 5 5, NSP5, SARS CORONAVIRUS MAIN PROTEINASE; COMPND 6 EC: 3.4.22.69; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 GENE: REP, 1A-1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS COVID-19, PROTEASE, SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2, KEYWDS 2 SARS-COV-2 3CL PROTEASE INHHIBITORS, HYDROLASE, HYDROLASE-HYDROLASE KEYWDS 3 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.J.MACHEN,S.LOVELL,K.P.BATTAILE,H.N.NGUYEN,S.D.CHAMANDI,H.R.PICARD, AUTHOR 2 T.K.MADDEN,H.A.THRUMAN,Y.KIM,W.C.GROUTAS,K.O.CHANG REVDAT 5 25-OCT-23 8CZX 1 REMARK REVDAT 4 01-FEB-23 8CZX 1 JRNL REVDAT 3 11-JAN-23 8CZX 1 JRNL REVDAT 2 03-AUG-22 8CZX 1 TITLE JRNL REVDAT 1 22-JUN-22 8CZX 0 JRNL AUTH C.S.DAMPALLA,H.N.NGUYEN,A.D.RATHNAYAKE,Y.KIM,K.D.PERERA, JRNL AUTH 2 T.K.MADDEN,H.A.THURMAN,A.J.MACHEN,M.M.KASHIPATHY,L.LIU, JRNL AUTH 3 K.P.BATTAILE,S.LOVELL,K.O.CHANG,W.C.GROUTAS JRNL TITL BROAD-SPECTRUM CYCLOPROPANE-BASED INHIBITORS OF CORONAVIRUS JRNL TITL 2 3C-LIKE PROTEASES: BIOCHEMICAL, STRUCTURAL, AND VIROLOGICAL JRNL TITL 3 STUDIES. JRNL REF ACS PHARMACOL TRANSL SCI V. 6 181 2023 JRNL REFN ESSN 2575-910 JRNL PMID 36654747 JRNL DOI 10.1021/ACSPTSCI.2C00206 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.46 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.030 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 70004 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.890 REMARK 3 FREE R VALUE TEST SET COUNT : 3422 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.4600 - 4.7600 0.97 2790 155 0.1625 0.1946 REMARK 3 2 4.7600 - 3.7800 0.98 2834 115 0.1393 0.1598 REMARK 3 3 3.7800 - 3.3000 0.99 2838 113 0.1554 0.2162 REMARK 3 4 3.3000 - 3.0000 0.99 2829 137 0.1766 0.2117 REMARK 3 5 3.0000 - 2.7800 0.98 2794 105 0.1762 0.2480 REMARK 3 6 2.7800 - 2.6200 0.98 2786 142 0.1782 0.2098 REMARK 3 7 2.6200 - 2.4900 0.99 2769 166 0.1856 0.2337 REMARK 3 8 2.4900 - 2.3800 0.98 2796 146 0.1860 0.2160 REMARK 3 9 2.3800 - 2.2900 0.99 2797 102 0.1849 0.2310 REMARK 3 10 2.2900 - 2.2100 0.99 2796 139 0.1941 0.2142 REMARK 3 11 2.2100 - 2.1400 0.99 2800 160 0.1905 0.2459 REMARK 3 12 2.1400 - 2.0800 0.99 2761 147 0.1904 0.2377 REMARK 3 13 2.0800 - 2.0200 0.99 2778 148 0.1910 0.2567 REMARK 3 14 2.0200 - 1.9700 0.98 2734 152 0.1889 0.2347 REMARK 3 15 1.9700 - 1.9300 0.96 2742 147 0.2016 0.2442 REMARK 3 16 1.9300 - 1.8900 0.98 2713 143 0.2091 0.2511 REMARK 3 17 1.8900 - 1.8500 0.98 2792 142 0.2228 0.2839 REMARK 3 18 1.8500 - 1.8200 0.98 2781 134 0.2149 0.2623 REMARK 3 19 1.8200 - 1.7800 0.98 2738 162 0.2297 0.2526 REMARK 3 20 1.7800 - 1.7500 0.98 2770 151 0.2330 0.2956 REMARK 3 21 1.7500 - 1.7300 0.98 2688 159 0.2374 0.2785 REMARK 3 22 1.7300 - 1.7000 0.98 2753 155 0.2468 0.2838 REMARK 3 23 1.7000 - 1.6700 0.98 2727 152 0.2478 0.2818 REMARK 3 24 1.6700 - 1.6500 0.97 2776 150 0.2623 0.2847 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.580 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.22 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.28 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8CZX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1000265780. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-MAR-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS-II REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.7 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 70053 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 48.630 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.03900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.62600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6XMK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% (W/V) PEG 1500, 100 MIB, PH 9.0, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 49.24850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A -3 REMARK 465 ASN A -2 REMARK 465 ILE A -1 REMARK 465 GLY A 0 REMARK 465 SER A 1 REMARK 465 SER A 301 REMARK 465 GLY A 302 REMARK 465 VAL A 303 REMARK 465 THR A 304 REMARK 465 PHE A 305 REMARK 465 SER B -3 REMARK 465 ASN B -2 REMARK 465 ILE B -1 REMARK 465 GLY B 0 REMARK 465 VAL B 303 REMARK 465 THR B 304 REMARK 465 PHE B 305 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 47 CG CD OE1 OE2 REMARK 470 MET A 49 CG SD CE REMARK 470 LYS A 61 CE NZ REMARK 470 ASN A 72 CG OD1 ND2 REMARK 470 GLN A 74 CG CD OE1 NE2 REMARK 470 ARG A 76 CG CD NE CZ NH1 NH2 REMARK 470 THR A 93 OG1 CG2 REMARK 470 LYS A 97 CE NZ REMARK 470 LYS A 100 CD CE NZ REMARK 470 LYS A 102 CD CE NZ REMARK 470 ASP A 153 CG OD1 OD2 REMARK 470 TYR A 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP A 155 CB CG OD1 OD2 REMARK 470 ARG A 222 CD NE CZ NH1 NH2 REMARK 470 PHE A 223 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASN A 277 CG OD1 ND2 REMARK 470 ARG A 279 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 294 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 298 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 5 CD CE NZ REMARK 470 SER B 46 OG REMARK 470 ASP B 48 CG OD1 OD2 REMARK 470 LEU B 50 CG CD1 CD2 REMARK 470 ARG B 60 CZ NH1 NH2 REMARK 470 ARG B 76 CD NE CZ NH1 NH2 REMARK 470 LYS B 97 CE NZ REMARK 470 LYS B 100 CD CE NZ REMARK 470 LYS B 102 CE NZ REMARK 470 LYS B 137 CD CE NZ REMARK 470 TYR B 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP B 155 CG OD1 OD2 REMARK 470 ALA B 191 CB REMARK 470 ARG B 222 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 236 CD CE NZ REMARK 470 ASN B 277 CG OD1 ND2 REMARK 470 ARG B 298 NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -122.02 50.12 REMARK 500 ASN A 51 70.54 -151.06 REMARK 500 ASN A 84 -125.17 51.87 REMARK 500 TYR A 154 -125.01 67.79 REMARK 500 PRO A 184 33.86 -87.81 REMARK 500 ARG A 217 25.92 -147.86 REMARK 500 ASP B 33 -129.94 54.16 REMARK 500 ASN B 84 -123.88 55.21 REMARK 500 TYR B 154 -116.07 56.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 725 DISTANCE = 5.84 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PJR B 401 REMARK 610 P8C B 402 DBREF 8CZX A 1 305 UNP P0DTD1 R1AB_SARS2 3264 3568 DBREF 8CZX B 1 305 UNP P0DTD1 R1AB_SARS2 3264 3568 SEQADV 8CZX SER A -3 UNP P0DTD1 EXPRESSION TAG SEQADV 8CZX ASN A -2 UNP P0DTD1 EXPRESSION TAG SEQADV 8CZX ILE A -1 UNP P0DTD1 EXPRESSION TAG SEQADV 8CZX GLY A 0 UNP P0DTD1 EXPRESSION TAG SEQADV 8CZX SER B -3 UNP P0DTD1 EXPRESSION TAG SEQADV 8CZX ASN B -2 UNP P0DTD1 EXPRESSION TAG SEQADV 8CZX ILE B -1 UNP P0DTD1 EXPRESSION TAG SEQADV 8CZX GLY B 0 UNP P0DTD1 EXPRESSION TAG SEQRES 1 A 309 SER ASN ILE GLY SER GLY PHE ARG LYS MET ALA PHE PRO SEQRES 2 A 309 SER GLY LYS VAL GLU GLY CYS MET VAL GLN VAL THR CYS SEQRES 3 A 309 GLY THR THR THR LEU ASN GLY LEU TRP LEU ASP ASP VAL SEQRES 4 A 309 VAL TYR CYS PRO ARG HIS VAL ILE CYS THR SER GLU ASP SEQRES 5 A 309 MET LEU ASN PRO ASN TYR GLU ASP LEU LEU ILE ARG LYS SEQRES 6 A 309 SER ASN HIS ASN PHE LEU VAL GLN ALA GLY ASN VAL GLN SEQRES 7 A 309 LEU ARG VAL ILE GLY HIS SER MET GLN ASN CYS VAL LEU SEQRES 8 A 309 LYS LEU LYS VAL ASP THR ALA ASN PRO LYS THR PRO LYS SEQRES 9 A 309 TYR LYS PHE VAL ARG ILE GLN PRO GLY GLN THR PHE SER SEQRES 10 A 309 VAL LEU ALA CYS TYR ASN GLY SER PRO SER GLY VAL TYR SEQRES 11 A 309 GLN CYS ALA MET ARG PRO ASN PHE THR ILE LYS GLY SER SEQRES 12 A 309 PHE LEU ASN GLY SER CYS GLY SER VAL GLY PHE ASN ILE SEQRES 13 A 309 ASP TYR ASP CYS VAL SER PHE CYS TYR MET HIS HIS MET SEQRES 14 A 309 GLU LEU PRO THR GLY VAL HIS ALA GLY THR ASP LEU GLU SEQRES 15 A 309 GLY ASN PHE TYR GLY PRO PHE VAL ASP ARG GLN THR ALA SEQRES 16 A 309 GLN ALA ALA GLY THR ASP THR THR ILE THR VAL ASN VAL SEQRES 17 A 309 LEU ALA TRP LEU TYR ALA ALA VAL ILE ASN GLY ASP ARG SEQRES 18 A 309 TRP PHE LEU ASN ARG PHE THR THR THR LEU ASN ASP PHE SEQRES 19 A 309 ASN LEU VAL ALA MET LYS TYR ASN TYR GLU PRO LEU THR SEQRES 20 A 309 GLN ASP HIS VAL ASP ILE LEU GLY PRO LEU SER ALA GLN SEQRES 21 A 309 THR GLY ILE ALA VAL LEU ASP MET CYS ALA SER LEU LYS SEQRES 22 A 309 GLU LEU LEU GLN ASN GLY MET ASN GLY ARG THR ILE LEU SEQRES 23 A 309 GLY SER ALA LEU LEU GLU ASP GLU PHE THR PRO PHE ASP SEQRES 24 A 309 VAL VAL ARG GLN CYS SER GLY VAL THR PHE SEQRES 1 B 309 SER ASN ILE GLY SER GLY PHE ARG LYS MET ALA PHE PRO SEQRES 2 B 309 SER GLY LYS VAL GLU GLY CYS MET VAL GLN VAL THR CYS SEQRES 3 B 309 GLY THR THR THR LEU ASN GLY LEU TRP LEU ASP ASP VAL SEQRES 4 B 309 VAL TYR CYS PRO ARG HIS VAL ILE CYS THR SER GLU ASP SEQRES 5 B 309 MET LEU ASN PRO ASN TYR GLU ASP LEU LEU ILE ARG LYS SEQRES 6 B 309 SER ASN HIS ASN PHE LEU VAL GLN ALA GLY ASN VAL GLN SEQRES 7 B 309 LEU ARG VAL ILE GLY HIS SER MET GLN ASN CYS VAL LEU SEQRES 8 B 309 LYS LEU LYS VAL ASP THR ALA ASN PRO LYS THR PRO LYS SEQRES 9 B 309 TYR LYS PHE VAL ARG ILE GLN PRO GLY GLN THR PHE SER SEQRES 10 B 309 VAL LEU ALA CYS TYR ASN GLY SER PRO SER GLY VAL TYR SEQRES 11 B 309 GLN CYS ALA MET ARG PRO ASN PHE THR ILE LYS GLY SER SEQRES 12 B 309 PHE LEU ASN GLY SER CYS GLY SER VAL GLY PHE ASN ILE SEQRES 13 B 309 ASP TYR ASP CYS VAL SER PHE CYS TYR MET HIS HIS MET SEQRES 14 B 309 GLU LEU PRO THR GLY VAL HIS ALA GLY THR ASP LEU GLU SEQRES 15 B 309 GLY ASN PHE TYR GLY PRO PHE VAL ASP ARG GLN THR ALA SEQRES 16 B 309 GLN ALA ALA GLY THR ASP THR THR ILE THR VAL ASN VAL SEQRES 17 B 309 LEU ALA TRP LEU TYR ALA ALA VAL ILE ASN GLY ASP ARG SEQRES 18 B 309 TRP PHE LEU ASN ARG PHE THR THR THR LEU ASN ASP PHE SEQRES 19 B 309 ASN LEU VAL ALA MET LYS TYR ASN TYR GLU PRO LEU THR SEQRES 20 B 309 GLN ASP HIS VAL ASP ILE LEU GLY PRO LEU SER ALA GLN SEQRES 21 B 309 THR GLY ILE ALA VAL LEU ASP MET CYS ALA SER LEU LYS SEQRES 22 B 309 GLU LEU LEU GLN ASN GLY MET ASN GLY ARG THR ILE LEU SEQRES 23 B 309 GLY SER ALA LEU LEU GLU ASP GLU PHE THR PRO PHE ASP SEQRES 24 B 309 VAL VAL ARG GLN CYS SER GLY VAL THR PHE HET PJR A 401 34 HET P8C A 402 34 HET PJR B 401 24 HET P8C B 402 24 HET PG4 B 403 13 HETNAM PJR [(1~{S},2~{R})-2-[4,4-BIS(FLUORANYL) HETNAM 2 PJR CYCLOHEXYL]CYCLOPROPYL]METHYL ~{N}-[(2~{S})-1- HETNAM 3 PJR [[(1~{S},2~{S})-1-[BIS(OXIDANYL)-OXIDANYLIDENE-$L^{5}- HETNAM 4 PJR SULFANYL]-1-OXIDANYL-3-[(3~{S})-2- HETNAM 5 PJR OXIDANYLIDENEPYRROLIDIN-3-YL]PROPAN-2-YL]AMINO]-4- HETNAM 6 PJR METHYL-1-OXIDANYLIDENE-PENTAN-2-YL]CARBAMATE HETNAM P8C [(1~{S},2~{R})-2-[4,4-BIS(FLUORANYL) HETNAM 2 P8C CYCLOHEXYL]CYCLOPROPYL]METHYL ~{N}-[(2~{S})-1- HETNAM 3 P8C [[(1~{R},2~{S})-1-[BIS(OXIDANYL)-OXIDANYLIDENE-$L^{5}- HETNAM 4 P8C SULFANYL]-1-OXIDANYL-3-[(3~{S})-2- HETNAM 5 P8C OXIDANYLIDENEPYRROLIDIN-3-YL]PROPAN-2-YL]AMINO]-4- HETNAM 6 P8C METHYL-1-OXIDANYLIDENE-PENTAN-2-YL]CARBAMATE HETNAM PG4 TETRAETHYLENE GLYCOL FORMUL 3 PJR 2(C24 H40 F2 N3 O8 S 1+) FORMUL 4 P8C 2(C24 H40 F2 N3 O8 S 1+) FORMUL 7 PG4 C8 H18 O5 FORMUL 8 HOH *407(H2 O) HELIX 1 AA1 SER A 10 GLY A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 ASN A 53 ARG A 60 1 8 HELIX 4 AA4 SER A 62 PHE A 66 5 5 HELIX 5 AA5 ILE A 200 ASN A 214 1 15 HELIX 6 AA6 THR A 226 TYR A 237 1 12 HELIX 7 AA7 THR A 243 LEU A 250 1 8 HELIX 8 AA8 LEU A 250 GLY A 258 1 9 HELIX 9 AA9 ALA A 260 GLY A 275 1 16 HELIX 10 AB1 THR A 292 CYS A 300 1 9 HELIX 11 AB2 SER B 10 GLY B 15 1 6 HELIX 12 AB3 HIS B 41 CYS B 44 5 4 HELIX 13 AB4 ASN B 53 ARG B 60 1 8 HELIX 14 AB5 SER B 62 PHE B 66 5 5 HELIX 15 AB6 ILE B 200 ASN B 214 1 15 HELIX 16 AB7 THR B 226 TYR B 237 1 12 HELIX 17 AB8 THR B 243 LEU B 250 1 8 HELIX 18 AB9 LEU B 250 GLY B 258 1 9 HELIX 19 AC1 ALA B 260 GLY B 275 1 16 HELIX 20 AC2 THR B 292 GLY B 302 1 11 SHEET 1 AA1 7 VAL A 73 LEU A 75 0 SHEET 2 AA1 7 LEU A 67 ALA A 70 -1 N ALA A 70 O VAL A 73 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N THR A 21 O LEU A 67 SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA1 7 VAL A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 AA1 7 VAL A 86 VAL A 91 -1 O LEU A 89 N VAL A 36 SHEET 7 AA1 7 VAL A 77 GLN A 83 -1 N SER A 81 O LYS A 88 SHEET 1 AA2 5 LYS A 100 PHE A 103 0 SHEET 2 AA2 5 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100 SHEET 3 AA2 5 VAL A 148 ASP A 153 -1 N ASN A 151 O SER A 158 SHEET 4 AA2 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 AA2 5 SER A 121 ALA A 129 -1 O TYR A 126 N VAL A 114 SHEET 1 AA3 3 LYS A 100 PHE A 103 0 SHEET 2 AA3 3 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100 SHEET 3 AA3 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165 SHEET 1 AA4 7 VAL B 73 LEU B 75 0 SHEET 2 AA4 7 LEU B 67 ALA B 70 -1 N VAL B 68 O LEU B 75 SHEET 3 AA4 7 MET B 17 CYS B 22 -1 N GLN B 19 O GLN B 69 SHEET 4 AA4 7 THR B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 5 AA4 7 VAL B 35 PRO B 39 -1 O VAL B 35 N LEU B 32 SHEET 6 AA4 7 VAL B 86 VAL B 91 -1 O LEU B 87 N CYS B 38 SHEET 7 AA4 7 VAL B 77 GLN B 83 -1 N ILE B 78 O LYS B 90 SHEET 1 AA5 5 LYS B 100 PHE B 103 0 SHEET 2 AA5 5 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 AA5 5 VAL B 148 ASP B 153 -1 N ASN B 151 O SER B 158 SHEET 4 AA5 5 THR B 111 TYR B 118 -1 N SER B 113 O PHE B 150 SHEET 5 AA5 5 SER B 121 ALA B 129 -1 O SER B 123 N ALA B 116 SHEET 1 AA6 3 LYS B 100 PHE B 103 0 SHEET 2 AA6 3 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 AA6 3 HIS B 172 THR B 175 -1 O ALA B 173 N MET B 165 LINK SG CYS A 145 C19APJR A 401 1555 1555 1.81 LINK SG CYS A 145 C19BP8C A 402 1555 1555 1.80 LINK SG CYS B 145 C19APJR B 401 1555 1555 1.81 LINK SG CYS B 145 C19BP8C B 402 1555 1555 1.80 CRYST1 54.857 98.497 58.682 90.00 107.65 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018229 0.000000 0.005800 0.00000 SCALE2 0.000000 0.010153 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017883 0.00000